Clinical Trial Update: Development of the Oncology Opportunity Cost Assessment Tool

View source ↗

Summary

This clinical trial update notes the completion of a study to develop the Oncology Opportunity Cost Assessment Tool, a methodology for assessing opportunity cos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Malignant Solid Neoplasm

Snippet

Sponsor: Thomas Jefferson University | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Status: COMPLETED